Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $364,944 | 319 | 99.4% |
| Food and Beverage | $2,136 | 71 | 0.6% |
| Education | $36.32 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $364,805 | 321 | $0 (2024) |
| BIOTRONIK INC. | $495.83 | 4 | $0 (2019) |
| Edwards Lifesciences Corporation | $350.00 | 1 | $0 (2024) |
| Amgen Inc. | $315.24 | 13 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $243.43 | 15 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $199.80 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $169.10 | 14 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $142.37 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $65.14 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $60.49 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,850 | 17 | Abbott Laboratories ($24,500) |
| 2023 | $29,772 | 33 | Abbott Laboratories ($29,772) |
| 2022 | $54,132 | 61 | Abbott Laboratories ($54,132) |
| 2021 | $52,514 | 61 | Abbott Laboratories ($52,514) |
| 2020 | $56,887 | 62 | Abbott Laboratories ($56,887) |
| 2019 | $50,395 | 54 | Abbott Laboratories ($50,250) |
| 2018 | $54,888 | 68 | Abbott Laboratories ($53,750) |
| 2017 | $43,678 | 42 | Abbott Laboratories ($43,000) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 12/19/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 12/19/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Vascular | ||||||
| 11/21/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 11/21/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 10/17/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 08/08/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Vascular | ||||||
| 06/26/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 05/30/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 05/16/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $4,250.00 | General |
| Category: Vascular | ||||||
| 05/16/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Vascular | ||||||
| 05/16/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 03/27/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 03/27/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 03/27/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Vascular | ||||||
| 02/26/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 02/09/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 11/20/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 11/20/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Vascular | ||||||
| 11/20/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Vascular | ||||||
| 11/20/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Vascular | ||||||
| 11/17/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Vascular | ||||||
| 10/15/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 10/15/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 10/15/2023 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,441 | 3,087 | $1.2M | $282,267 |
| 2022 | 20 | 1,353 | 2,722 | $1.0M | $249,191 |
| 2021 | 17 | 1,437 | 3,276 | $1.1M | $294,616 |
| 2020 | 25 | 1,800 | 3,587 | $1.1M | $298,874 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 1,105 | $301,665 | $81,178 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 746 | $306,606 | $76,971 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 143 | 178 | $137,238 | $27,453 | 20.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 130 | 132 | $116,952 | $22,820 | 19.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 144 | $56,736 | $15,897 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $44,450 | $9,811 | 22.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 50 | 53 | $42,400 | $9,543 | 22.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 46 | 48 | $37,632 | $8,835 | 23.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 72 | 87 | $25,491 | $6,388 | 25.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 28 | $29,652 | $5,638 | 19.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 29 | 31 | $17,081 | $3,572 | 20.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 23 | 24 | $10,104 | $2,692 | 26.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 176 | 192 | $12,864 | $2,282 | 17.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 14 | 29 | $25,520 | $1,913 | 7.5% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Office | 2023 | 13 | 15 | $9,195 | $1,828 | 19.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $3,564 | $1,365 | 38.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 11 | 26 | $5,596 | $1,339 | 23.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 15 | 30 | $3,000 | $682.08 | 22.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,260 | $647.64 | 51.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 49 | 56 | $740.00 | $470.40 | 63.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 19 | 19 | $1,748 | $402.99 | 23.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 18 | $990.00 | $316.62 | 32.0% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $1,260 | $221.92 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 702 | $288,746 | $71,210 | 24.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 150 | 945 | $257,985 | $63,444 | 24.6% |
About Dr. Ozgen Dogan, MD
Dr. Ozgen Dogan, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841392131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ozgen Dogan, MD has received a total of $367,116 in payments from pharmaceutical and medical device companies, with $24,850 received in 2024. These payments were reported across 398 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($364,944).
As a Medicare-enrolled provider, Dogan has provided services to 6,031 Medicare beneficiaries, totaling 12,672 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 09/05/2006
- Last Updated 06/05/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841392131
Products in Payments
- XIENCE V (Device) $77,316
- Mitra Clip system (Device) $61,000
- Xience cornary stent systems (Device) $42,500
- Xience V coronary stent system (Device) $38,750
- Absorb (Device) $33,000
- PORTICO (Device) $28,882
- Portico Transcatheter Aortic Heart Valve (Device) $21,764
- Portico Transcatheter Aortic HV (Device) $16,632
- Tricuspid Valve Repair System (Device) $12,250
- ABSORB (Device) $11,000
- Absorb GT1 (Device) $9,000
- ABSORB GT1 (Device) $2,000
- MitraClip System (Device) $2,000
- Perclose ProGlide suture mediated closure system (Device) $1,000
- Gallant CRT-D (Device) $250.00
- Vascular Closure Devices (Device) $250.00
- ENTRESTO (Drug) $243.43
- MITRACLIP (Device) $206.19
- WATCHMAN (Device) $199.80
- Corlanor (Drug) $160.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Joshua Kerstein, Md, MD
Cardiovascular Disease — Payments: $216,817